Navigation Links
Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program

ur revenues may be adversely affected.

Certain of our products have experienced manufacturing issues. If the issues recur and cannot be resolved, our ability to acquire product for sale and sampling will be adversely affected. We may incur unexpected costs in integrating new products into our operations.

We may be unable to develop or market line extensions for our products including Prenate, Sular, Triglide, Nitrolingual, Altoprev and Fortamet, or, even if developed, obtain patent protection for our line extensions; further, introductions by us of line extensions of our existing products may require that we make unexpected changes in our estimates for future product returns and reserves for obsolete inventory. If these risks occur, our financial results could be adversely affected.

If we have difficulties acquiring new products or rights to market new products from third parties, our financial results could be adversely impacted. Our licensor/supplier can terminate our rights to commercialize Nitrolingual and the 60 dose size of this product has not yet met our expectation.

We depend on a small senior management group, the departure of any member of which would likely adversely affect our business if a suitable replacement member could not be retained.

An adverse interpretation or ruling by one of the taxing jurisdictions in which we operate could adversely impact our operating results. An adverse judgment in the securities class action litigation in which we and certain current and former directors and executive officers are defendants could have a material adverse effect on our financial results and liquidity. Our business is subject to increasing government price controls and other healthcare cost containment measures. Side effects or marketing or manufacturing problems with our products could result in product liability claims which could be costly to defend and could result in the withdrawal or recall of products from the mar
'"/>




Page: 1 2 3 4

Related medicine technology :

1. SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:7/6/2015)... July 6, 2015  EndoChoice Holdings, Inc. (NYSE:  GI) ... 2015 financial results on Thursday, August 6, 2015 before ... a conference call on Thursday, August 6, 2015 at ... numbers are (866) 807-9684 for domestic callers and (412) ... conference call will be available on the investor relations ...
(Date:7/6/2015)... 6, 2015 Flower Orthopedics, the creator ... FlowerCube™, announced today that it has received CE ... significant expansion of the innovative FlowerCube™ concept in ... encompasses Flower Orthopedics, entire product line, which consists ... lower extremities. Consisting of more than 400 implants, ...
(Date:7/6/2015)... 2015 Research and Markets( ... "Pharmaceutical Packaging Market in North America 2015-2019" report ... in North America to grow ... International regulations regarding safe drug delivery ... in turn fuels adoption of sustainable packaging. Various raw ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Flower Orthopedics cleared to enter the European Union 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3
... 04, 2007 /PRNewswire/ -- GlaxoSmithKline today,announced results ... in,advanced or metastatic renal cell carcinoma (RCC), ... trials were presented at the,43rd Annual Meeting ... in Chicago. The results observed in these ...
... Calif., June 04, 2007 /PRNewswire/ -- (SEND2PRESS,NEWSWIRE) -- ... historic landmark in medical oncology and a,definitive benchmark ... first clinical report of its kind, Le Morte ... the International Journal of,Oncology, Vol.30, pp. 1297-1307 -- ...
Cached Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
(Date:7/7/2015)... ... July 07, 2015 , ... CSG Government Solutions, ... by the Department of Vermont Health Access to provide Quality Assurance (QA) and ... and Integrated Contact Center System project. , Vermont is implementing a strategic approach ...
(Date:7/6/2015)... Los Angeles, CA (PRWEB) , ... July 06, 2015 , ... ... resource for finding medical providers for personal injury victims. Throughout the company’s history ... that collectively deliver the care victims need in their recovery. And while Doctors ...
(Date:7/6/2015)... ... July 06, 2015 , ... Human induced pluripotent stem cells ... generated from adult cells, such as blood or skin, can replicate indefinitely and ... , iPSC-derived cardiomyocytes have proven valuable in helping to detect ...
(Date:7/6/2015)... ... July 06, 2015 , ... PristineHydro ( http://www.pristinewaterfilters.com ) has ... and impurities; it also properly mineralizes the water with electrolyte salts.  Common tap ... harmful contaminants are a byproduct of how the water is treated chemically.  In ...
(Date:7/6/2015)... ... July 06, 2015 , ... University of Pittsburgh Cancer Institute (UPCI) ... testing to reflect newly available tests that better incorporate personalized medicine into diagnosing the ... thyroid cancer tests is published in the July issue of the scientific journal ...
Breaking Medicine News(10 mins):Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5
... researchers at Massachusetts General Hospital and University of Michigan ... intrinsic (resting-state) brain connectivity and spontaneous pain intensity in ... interaction of multiple brain networks, offering greater understanding of ... and in the August issue of Arthritis & ...
... , THURSDAY, July 29 (HealthDay News) -- Following a ... Brilinta Wednesday, cardiologists say the drug could be a ... a 7-to-1 vote, the U.S. Food and Drug Administration,s ... the drug for heart patients undergoing angioplasty or stenting ...
... Drug Administration (FDA) received reports of malignancies in children using ... associated risk and prompting an investigation. Researchers from the FDA ... using infliximab, etanercept, and adalimumab and their report is published ... a journal of the American College of Rheumatology. ...
... Among black teens, vitamin D deficiency is associated with arterial ... -- but adequate supplementation may resolve the problem, a new ... vitamin D, but nearly all of the 44 male and ... even though they lived in a sun-soaked region, the researchers ...
... are likely the cause of the feminization of fish say ... of their study in the journal Environmental Toxicology and ... the huge geographical area we covered. We found that chemicals ... to harm fish were present along approximately 600 km of ...
... HealthDay Reporter , WEDNESDAY, July 28 (HealthDay News) -- For ... joint from stem cells, albeit in rabbits not humans. And the ... and bear weight, virtually like normal rabbits," said Dr. Jeremy Mao, ... The Lancet . "This was the first regeneration of the entire ...
Cached Medicine News:Health News:Resting brain activity associated with spontaneous fibromyalgia pain 2Health News:Experts Support FDA Panel's Backing of New Blood Thinner 2Health News:Experts Support FDA Panel's Backing of New Blood Thinner 3Health News:Experts Support FDA Panel's Backing of New Blood Thinner 4Health News:TNF blockers may increase the risk of malignancy in children 2Health News:TNF blockers may increase the risk of malignancy in children 3Health News:Black Teens May Need Higher Vitamin D Supplementation 2Health News:Gender-bending fish on the rise in southern Alberta 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 3
Greenberg universal retractor case, with four compartments to hold various components....
Length-9 (229 mm) Tapered retractor blades....
Kit is supplied with four secondary bars. Secondary bars attach to primary bar. Length 12 (305 mm)....
Length 10 (254 mm). The Greenberg Handrest attaches to short coupler or a secondary bar....
Medicine Products: